8.98
price up icon11.55%   0.93
after-market Handel nachbörslich: 9.58 0.60 +6.68%
loading

Cervomed Inc Aktie (CRVO) Neueste Nachrichten

pulisher
07:34 AM

CervoMed (CRVO) Retains Buy Rating Amidst Steady Price Target | CRVO Stock News - GuruFocus

07:34 AM
pulisher
12:21 PM

CervoMed to report 32-week extension phase results for DLB treatment - Investing.com Australia

12:21 PM
pulisher
Jul 24, 2025

CervoMed to Present New Data from Phase 2b RewinD-LB Study - GlobeNewswire

Jul 24, 2025
pulisher
Jul 24, 2025

CervoMed to Reveal Critical 32-Week RewinD-LB Trial Results for Lewy Body Dementia Treatment at AAIC 2025 - Stock Titan

Jul 24, 2025
pulisher
Jul 24, 2025

What analysts say about CervoMed Inc. stockMarket-leading growth rates - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 23, 2025

CervoMed Inc. Stock Analysis and ForecastAccelerated financial growth - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Is CervoMed Inc. a good long term investmentDouble or triple returns - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

What drives CervoMed Inc. stock priceExtraordinary performance - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 16, 2025

CervoMed’s Dementia Drug Saga Tests Investor Patience And Nerves - Finimize

Jul 16, 2025
pulisher
Jul 15, 2025

How CervoMed Inc. stock performs during market volatilityStrategic High Profit Opportunities - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why CervoMed Inc. stock attracts strong analyst attentionTrend Based Entry Alerts - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes CervoMed Inc. stock price move sharplyFree Stock Selection with 300% Return - Newser

Jul 15, 2025
pulisher
Jul 13, 2025

Brokerages Set CervoMed Inc. (NASDAQ:CRVO) Price Target at $22.57 - Defense World

Jul 13, 2025
pulisher
Jul 09, 2025

CervoMed Strengthens Leadership with Technical Operations Hire to Advance Neflamapimod Toward Phase 3 - MSN

Jul 09, 2025
pulisher
Jul 08, 2025

CervoMed Inc. to Present Late-Breaking Data on Neflamapimod at Alzheimer’s Association International Congress 2025 - Nasdaq

Jul 08, 2025
pulisher
Jul 08, 2025

CervoMed Announces Late-Breaking Presentations at Alzheimer’s Association® International Congress 2025 - GlobeNewswire

Jul 08, 2025
pulisher
Jul 08, 2025

Late-Breaking Phase 2b Results: CervoMed's Novel DLB Drug Shows Effects on Clinical Progression - Stock Titan

Jul 08, 2025
pulisher
Jun 30, 2025

CervoMed Inc.(NasdaqCM: CRVO) dropped from Russell 2000 Dynamic Index - MarketScreener

Jun 30, 2025
pulisher
Jun 30, 2025

CervoMed Inc.(NasdaqCM: CRVO) dropped from Russell 3000E Index - MarketScreener

Jun 30, 2025
pulisher
Jun 30, 2025

CervoMed Inc.(NasdaqCM: CRVO) dropped from Russell 2000 Index - MarketScreener

Jun 30, 2025
pulisher
Jun 27, 2025

CervoMed Inc. (NASDAQ:CRVO) Shares Bought by Rhumbline Advisers - Defense World

Jun 27, 2025
pulisher
Jun 25, 2025

CervoMed Stockholders Approve Key Proposals at Annual Meeting - TipRanks

Jun 25, 2025
pulisher
Jun 15, 2025

CervoMed Inc. (NASDAQ:CRVO) Receives Average Recommendation of “Moderate Buy” from Analysts - Defense World

Jun 15, 2025
pulisher
Jun 12, 2025

CervoMed’s (CRVO) “Buy” Rating Reaffirmed at D. Boral Capital - Defense World

Jun 12, 2025
pulisher
Jun 11, 2025

CervoMed (CRVO) Receives Continued 'Buy' Rating with Target Pric - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

CervoMed (CRVO) Receives Continued 'Buy' Rating with Target Price Held Steady | CRVO Stock News - GuruFocus

Jun 11, 2025
pulisher
Jun 10, 2025

CervoMed (CRVO) Strengthens Leadership with Key Executive Appoin - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

CervoMed (CRVO) Strengthens Leadership with Key Executive Appointment | CRVO Stock News - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

CervoMed appoints Marco Verwijs as EVP, technical operations - TipRanks

Jun 10, 2025
pulisher
Jun 10, 2025

CervoMed Announces New Hire to Support Neflamapimod Development and Commercialization - GlobeNewswire

Jun 10, 2025
pulisher
Jun 10, 2025

CervoMed Accelerates Phase 3 DLB Drug Development With Key Manufacturing Expert Hire - Stock Titan

Jun 10, 2025
pulisher
Jun 08, 2025

CRVOCervoMed Reports First Quarter 2025 Financial Results and Provides Corporate Updates - mx.advfn.com

Jun 08, 2025
pulisher
Jun 07, 2025

Nuveen Asset Management LLC Acquires 22,104 Shares of CervoMed Inc. (NASDAQ:CRVO) - Defense World

Jun 07, 2025
pulisher
Jun 05, 2025

BNP Paribas Financial Markets Purchases New Position in CervoMed Inc. (NASDAQ:CRVO) - Defense World

Jun 05, 2025
$23.40
price down icon 0.97%
$36.67
price up icon 0.22%
$103.95
price up icon 0.42%
$28.67
price up icon 3.99%
$115.31
price up icon 0.65%
biotechnology ONC
$291.47
price down icon 1.68%
Kapitalisierung:     |  Volumen (24h):